Royal DSM announced a major reduction of vitamin C production in Jiangshan, China, with immediate effect. DSM will reevaluate a ramp-up of the production in 2023 after the Chinese New Year.

Continuation of usual output levels at current pricing is not sustainable and DSM prioritizes reducing its vitamin C stocks in the coming period. Allocation procedures have been activated across the global DSM production network to ensure supply. The Quali-C™ production in Dalry, Scotland, is not impacted.

This local, temporary measure reconfirms DSM’s strategy to leverage its global production infrastructure to ensure long-term sustainable and profitable production of key vitamins. Reducing output will also support DSM’s aim to lower its working capital.

The measure follows the halt of animal-grade vitamin A and reduction of vitamin E production in Switzerland for at least two months commencing on January 2, 2023.